120 related articles for article (PubMed ID: 6937939)
21. The effects of sodium carbenoxolone on the stability of cellular membranes.
Symons AM; Parke DV
Scand J Gastroenterol Suppl; 1980; 65():3-10. PubMed ID: 6937938
[TBL] [Abstract][Full Text] [Related]
22. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
Lai CM; Moore P; Quon CY
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of leukotriene formation as a mode of action of gastroprotective drugs.
Lange K; Peskar BA; Peskar BM
Prog Clin Biol Res; 1987; 242():283-8. PubMed ID: 3671388
[No Abstract] [Full Text] [Related]
24. [Drug interactions as a cause for iatrogenic diseases in the aged. A tabulated presentation].
Hitzenberger G
Aktuelle Gerontol; 1983 Sep; 13(5):173-6. PubMed ID: 6139032
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular action of a new carbenoxolone derivative.
Filczewski M; Kosmala M; Oledzka K
Pol J Pharmacol Pharm; 1988; 40(3):233-9. PubMed ID: 3241764
[TBL] [Abstract][Full Text] [Related]
26. The actions of carbenoxolone on enzymes and their relation to its therapeutic effect.
Roberts NB; Taylor WH
Scand J Gastroenterol Suppl; 1980; 65():11-7. PubMed ID: 6782651
[TBL] [Abstract][Full Text] [Related]
27. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial.
Cook PJ; Vincent-Brown A; Lewis SI; Perks S; Jewell DP; Reed PI
Scand J Gastroenterol Suppl; 1980; 65():93-101. PubMed ID: 7010531
[TBL] [Abstract][Full Text] [Related]
28. Sucralfate and carbenoxolone in the treatment of functional disturbances following partial gastrectomy.
Corsini G; Bresci G; Capria A; Geloni M; Rindi G
Int J Tissue React; 1984; 6(2):185-8. PubMed ID: 6547414
[TBL] [Abstract][Full Text] [Related]
29. Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer.
Schenk J; Schmack B; Rösch W; Domschke W
Scand J Gastroenterol Suppl; 1980; 65():103-7. PubMed ID: 7010527
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of stomach ulcer with the Bulgarian preparation Farmaxolon].
Brailski Kh; Dimitrov B; Matov V; Damianov B
Vutr Boles; 1987; 26(3):43-50. PubMed ID: 3303693
[TBL] [Abstract][Full Text] [Related]
31. [Gastric emptying in dyspeptic syndromes during treatment with a combination of carbenoxolone and metoclopramide, studied with a meal labeled with 99mTc colloidal sulfate].
Sciarretta G; Turba E; Verri A; Pinetti P; Malaguti P
Clin Ter; 1980 Jun; 93(6):639-48. PubMed ID: 7428319
[No Abstract] [Full Text] [Related]
32. [Value of biogastrone and duodenal biogastrone in the treatment of peptic ulcer].
Stadnicki A
Pol Tyg Lek; 1979 Jun; 34(26):1029-31. PubMed ID: 503921
[No Abstract] [Full Text] [Related]
33. [Alcohol and drugs].
De Baere H
Tijdschr Gastroenterol; 1976; 19(2):117-23. PubMed ID: 1013984
[No Abstract] [Full Text] [Related]
34. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Eur J Clin Pharmacol; 1980 Apr; 17(4):285-93. PubMed ID: 6995130
[No Abstract] [Full Text] [Related]
35. Complex formation between macromolecules and drugs. X. Binding of tolbutamide, chlorpropamide and carbutamide to human serum albumin, and the competition between tolbutamide or chlorpropamide and carbutamide or 4-sulfanilamido-2,6-dimethylpyrimidine for binding sites on human serum albumin.
Nilsson B; Agren A
Acta Pharm Suec; 1974 Sep; 11(4):391-400. PubMed ID: 4412551
[No Abstract] [Full Text] [Related]
36. [Carbenoxolone in the treatment of duodenal ulcer].
Kadish U; Neeman A
Harefuah; 1979 Sep; 97(5-6):111-2. PubMed ID: 540839
[No Abstract] [Full Text] [Related]
37. Effect of sulphonylureas (tolazamide, tolbutamide and chlorpropamide) on the metabolism of diphenylhydantoin in the rat.
Wesseling H; Thurkow I; Mulder G
Biochem Pharmacol; 1973 Dec; 22(23):3033-40. PubMed ID: 4761563
[No Abstract] [Full Text] [Related]
38. Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative.
Goldberg GS; Moreno AP; Bechberger JF; Hearn SS; Shivers RR; MacPhee DJ; Zhang YC; Naus CC
Exp Cell Res; 1996 Jan; 222(1):48-53. PubMed ID: 8549672
[TBL] [Abstract][Full Text] [Related]
39. [Comparative study of placebo, atropine, cimetidine and carbenoxolone in patients with duodenal ulcer].
Tárnok F; Jávor T; Mózsik G; Nagy L; Patty I; Rumi G; Solt I
Orv Hetil; 1980 Jun; 121(26):1567-70. PubMed ID: 7454266
[No Abstract] [Full Text] [Related]
40. [Hypokalemic myopathy secondary to carbenoxolone ulcer therapy (case report)].
Corsi FM; Galgani S; Giacanelli M; Piazza G
Riv Neurobiol; 1980; 26(3):350-6. PubMed ID: 7336082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
